[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"anorexia-in-adolescence\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:anorexia-in-adolescence":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,51,77],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":33,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":40,"lastUpdatePostDateStruct":41,"startDateStruct":44,"completionDateStruct":46,"leadSponsor":48,"locationsCount":4},"100561684","fecal-microbiota-transplant-for-anorexia-nervosa-100561684",false,"NCT06593366","Fecal Microbiota Transplant for Anorexia Nervosa","A Pilot Feasibility Randomized Controlled Trial of Fecal Microbiota Transplant for Adolescent Anorexia Nervosa","FMT-AN","Inclusion Criteria: All study subjects will have been diagnosed with AN (restricting type or binge eating\u002Fpurging type) by the primary physician on the ED team, as per standard approach. Study participants will:\n\n* Be 12-17 years-old at time of recruitment\n* Have capacity to consent\n* Be assigned female sex at birth (may be gender diverse)\n* Be active patients in the pediatric ED program at MCH\n* Have a weight that is \\\u003C85% of the Treatment Goal Weight, as determined by the treating physician\n\nExclusion Criteria: Potential study subjects will be excluded due to the following reasons:\n\n* Exposure to antibiotics within two weeks of study randomization\n* Initiation of new probiotics \u002F oral nutritional supplements within two weeks of randomization\n* Active pregnancy\n* Active psychosis or suicidal ideation\n* Other comorbidities that may affect weight or the gut microbiome including celiac disease, inflammatory bowel disease (or other conditions as determined by the study team)","FEMALE","12 Years","17 Years",{"count":21,"type":22},20,"ESTIMATED","INTERVENTIONAL",[25],"NA","The purpose of this pilot randomized-controlled trial is to determine whether Fecal Microbiota Transplant (FMT) treatment demonstrates feasibility, acceptability, and prelinary effectiveness among patients with anorexia nervosa (AN). Specifically, the investigators aim to compare changes in weight, gut microbiome, urine, blood biomarkers and mood symptoms between participants receiving the FMT intervention and placebo.",[28,29,30,31,32],"Anorexia Nervosa Restricting Type","Anorexia Nervosa","Anorexia in Adolescence","Anorexia in Children","Anorexia",[34,35,36,37,38],"anorexia nervosa","fecal microbiota transplant","pilot study","randomized controlled trial","feasibility","NOT_YET_RECRUITING","2026-05-22",{"date":42,"type":43},"2026-05-27","ACTUAL",{"date":45,"type":22},"2026-06-01",{"date":47,"type":22},"2027-06-01",{"name":49,"class":50},"Hamilton Health Sciences Corporation","OTHER",{"id":52,"slug":53,"hasResults":11,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":4,"eligibilityCriteria":57,"healthyVolunteers":11,"sex":58,"minAge":59,"maxAge":60,"enrollmentInfo":61,"targetDuration":4,"studyType":63,"phases":4,"briefSummary":64,"conditions":65,"keywords":4,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":76},"100457382","secretin-in-refeeding-100457382","NCT05235867","Secretin in Refeeding","Secretin Levels in Refeeding-induced Polyuria (Cross Section)","Inclusion Criteria:\n\n* Group 1:\n\n  * male and female patients\n  * age 13-24 years\n  * diagnosis of restrictive-type anorexia nervosa\n  * hospitalization for nutritional support\n  * \\>4 cc\u002Fkg\u002Fday of urine output (a.k.a. \"fluid dumpers\"; n=5)\n* Group 2:\n\n  * male and female patients\n  * age 13-24 years\n  * diagnosis of restrictive-type anorexia nervosa\n  * hospitalization for nutritional support\n  * \\\u003C2 cc\u002Fkg\u002Fd of urine output (a.k.a. \"non-dumpers\"; n=5)\n\nExclusion Criteria:\n\n* 5150 hold\n* Anti-depressant, anti-psychotic, or anticonvulsant medications\n* Previous hospitalization within the past 6 months\n* Underlying metabolic disorder not related to anorexia nervosa (including chronic kidney disease, renal tubular disorders, and underlying endocrine disorders)\n* Pregnancy\n* NG or G-tube feeds after day 2 of hospitalization\n* \\> 10% of nutritional needs from supplemental feeds","ALL","13 Years","24 Years",{"count":62,"type":22},10,"OBSERVATIONAL","Patients with restrictive-type anorexia nervosa who are admitted to the hospital for feeding often urinate excessive amounts. Others have changes in the way that they handle acid and base. These issues prolong hospitalizations. Current data suggest that one hormone--named secretin--may control both urine output and how the body handles acid and base. This study will evaluate whether secretin levels are different in anorexic patients who urinate an excessive amount compared to those who urinate normal amounts. For this study, patients will have one extra blood draw before and after one meal during their hospitalization. The blood draw before the meal coincides with a standard of care blood draw. Also after the meal, subjects will be asked to provide one extra urine sample. Information from subject's medical records will also be used.",[30],"RECRUITING","2026-02-09",{"date":69,"type":43},"2026-02-12",{"date":71,"type":43},"2022-02-01",{"date":73,"type":22},"2027-12-31",{"name":75,"class":50},"University of California, Los Angeles",1,{"id":78,"slug":79,"hasResults":11,"nctId":80,"briefTitle":81,"officialTitle":81,"acronym":82,"eligibilityCriteria":83,"healthyVolunteers":11,"sex":58,"minAge":84,"maxAge":19,"enrollmentInfo":85,"targetDuration":4,"studyType":23,"phases":87,"briefSummary":88,"conditions":89,"keywords":90,"overallStatus":66,"whyStopped":4,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":101,"locationsCount":76},"100574447","family-based-telemedicine-vs-inpatient-anorexia-nervosa-treatment-fiat-100574447","NCT06759402","Family-based Telemedicine vs. Inpatient Anorexia Nervosa Treatment (FIAT)","FIAT","Inclusion Criteria:\n\n* restrictive and bulimic subtypes of anorexia nervosa (ICD-10: F50.00; F50.01)\n* inpatient treatment indication according to S3 guideline\n* weight \\\u003C 3. BMI-percentile or\n* weight \\\u003C10. percentile and psychiatric comorbidity\u002Frapid weight loss\u002Flack of weight gain during outpatient treatment over last three month\n* planned inpatient treatment\n* insured with one of the participating health insurance companies\n* stable internet connection\n\nExclusion Criteria:\n\n* weight \\\u003C67%mBMI\n* acute self harm or danger to others\n* acute psychosis or suicidal tendencies\n* current substance abuse\n* child abuse or domestic violence in the family\n* insured with other health insurance company\n* judicial placement order for inpatient treatment\n* known, currently existing child protection problems or proceedings by the family court","8 Years",{"count":86,"type":22},200,[25],"The FIAT study is funded by the Innovationsfonds of the German Ministry of Health via the DLR Project Management Agency. The study will be conducted in up to 21 hospitals across Germany and in collaboration with 10 German public health insurance companies. The primary aim of this study is to compare Family-Based Treatment delivered via telehealth (FBT) with inpatient multimodal therapy (IMT) with respect to treatment outcomes and health economic data. The results of the study will serve as a basis for the decision on the inclusion of FBT in the German S3 guidelines and the future reimbursement of FBT by public health insurances in Germany.",[29,30],[91,92,93,94],"Psychotherapy","Family Based Treatment","RCT","Inpatient Treatment","2025-02-11",{"date":97,"type":43},"2025-02-13",{"date":99,"type":43},"2025-01-31",{"date":73,"type":22},{"name":102,"class":50},"Charite University, Berlin, Germany"]